Abstract 1 2 Acquiring a sufficiently powered cohort of control samples can be time consuming or, 3 sometimes, impossible. Accordingly, an ability to leverage control samples that were already 4 collected and sequenced elsewhere could dramatically improve power in all genetic association 5 studies. However, since majority of the genotyped and sequenced human DNA samples to date 6 are subject to strict data sharing regulations, large-scale sharing of, in particular, control samples 7 is extremely challenging. Using insights from image recognition, we developed a method allowing 8 selection of the best-matching controls in an external pool of samples that is compliant with 9 personal genotype data protection restrictions. Our approach uses singular value decomposition 10 of the matrix of case genotypes to rank controls in another study by similarity to cases. We 11 demonstrate that this recovers an accurate case-control association analysis for both ultra-rare 12 and common variants and implement and provide online access to a library of ~17,000 controls 13 that enables association studies for case cohorts lacking control subjects. 14 15 Introduction 16
Introduction 16 17
Traditionally, genetic association studies require construction of a dataset consisting of 18 both case and control genotypes. With this, one tries to eliminate all potential biases (technical 19 or ancestral) between case and control cohorts, ensuring that discovered associations are 20 phenotype-driven. While technical biases could be significantly diminished without explicit 21 sharing of sensitive individual-level data by using the same sequencing technology and data 22 association study . 13 In this work, we used insights from image recognition algorithms 4 and developed a 14 rigorous methodology for matching background variation in independent datasets without 15 explicit genotype sharing. Specifically, we used singular value decomposition (Supplementary 16 Importantly, for a given genotype matrix G of cohort of cases, left singular vectors matrix -U, can 21 be used alone to reconstruct original matrix of genotypes, and therefore can be shared 22 the matrix approximation properties of the SVD it is known that the first singular vector 13 represents "dominating" direction of the data matrix. Thus, if folded back to case genotypes, 14 vectors ui should be similar in global LD structure to the case cohort. 15
It is established that these methods perform well if the following conditions are met: each 16 sample could be well characterized by a few of the first singular vectors; an expansion in terms 17 of the first few singular vectors discriminates well between the sample ancestries 4 ; cases 18 represent a relatively homogenous ancestral cluster (that is, if you are conducting a meta-analysis 19 across two diverse ancestries, you should run the two case groups separately). Therefore, we can 20 compute how well a prospective control sample can be represented in the basis of case cohort. 21
This can be done by computing residual vector in the least squares problem of the type: 22 threshold an association test should be performed using allele frequencies for DNA variants used 11 for matching and genomic inflation factor 5 estimated. Largest set of controls delivering 12 acceptably null distribution of the test statistic (lGC£1.05) should be then taken as a matched set 13 of controls. Allele frequencies for variants of interest should then be computed in matched 14 control dataset and could be shared with client to run full-scale association test (Toy example of  15 case-control study with 2 cases and 2 controls is explained at Supplementary Figure S2) . Unlike 16 individual level data, such summary statistic sharing from most consented resources is routinely 17 To validate our approach, we used 1000 genomes genotyping data. Entire dataset was subjected 1 to per genotype and per individual quality check procedures (Supplementary Figure S3) . Final 2 dataset consisted of 10,000 LD-pruned autosomal variants and 1,708 non-related samples ( Figure  3 
2A).
To simulate an association study we divided the dataset into 100 "cases" of European 4 ancestry (as provided by 1000 genomes project annotation) and "control pool" of 1608 samples 5 that included 359 European samples (Figure 2A,B) . We simulated an association study without 6 genotype sharing by separating every case cohort from control candidates ( Figure 2C ). For a case 7 group SVD was computed and top 5 left singular vectors were used for control matching 8 purposes. Residual vector norm was computed for every control, ranking controls by similarity to 9 case cohort ( Figure 2D ) and separating ancestries ( Figure 2E ). Choosing different residual norm 10 thresholds allows to create different pools of controls of variable matching quality (Figure 2D,E) . 11 Indeed, PCA plot built using shared genotypes confirmed that increase in residual vector norm 12 threshold results in departure from original European case cluster delivering poor control 13 matching quality ( Figure 2F ). To select optimal threshold value, allele frequency of variants in 14 cases is used to estimate association test statistics and genomic control factor for different 15 residual vector norm thresholds (Figure 2G,H) . Largest control pool size with null distributed 16 association test statistics (e.g. lGC£1.05) was selected as optimally matched set ( Figure 2I ). 100 17 simulation instances with random 100 "case" cohorts (100 European samples each) yielded on 18 average selection of 428 controls (SD=26.6) with estimated mean genomic inflation lGC=1.049 19 (SD=8.76x10 -4 ) ( Figure 2J ). These control sets covered nearly all European samples in Control 20
Pool and also selected a small number of controls annotated in 1000 Genomes as Latin-21
Americans (though still keeping genomic inflation factor below 1.05). In 100 random selections 22 of "case" cohort (100 European samples each), we identified a group of Latin-Americans 1 recurrently selected for a matched control set (Supplementary Figure S4A) . It appears to be the 2 closest to Europeans on PCA (Supplementary Figure S4B) . Selection of samples with non-3 matching ancestry annotation is bound to the statistical power of the association testing used for 4 genomic inflation estimation, thus, the more cases are used for association testing the fewer 5 controls of non-matching ancestry annotation are selected (Supplementary Figure S4C) . Though, 6 with any set of case cohort genomic inflation factor is below 1.05 implying neglectable effect on 7 further phenotypic association test results (Supplementary Figure S4D) . 
Exome sequencing data 13
Further, we sought to test how this approach performs in exome sequencing data with 14 relatively small number of LD-pruned DNA variants. We used an aggregated set of whole exome 15 sequences consented for joint variant calling resulting in 37,607 samples to build a test dataset 16 (Supplementary Table S1 ). Further, a subset of LD-pruned variants used for PCA in ExAC 17 database 9 was subjected to quality check: only genotypes with DP>10, GQ>20 and variants with 18 less than 500 missing genotypes were allowed, resulting in 4,561 DNA variant left for analysis. 19
Samples were further analyzed for relatedness and related samples were removed: in pairs of 20 samples with ; < < 0.2 only one sample was randomly kept (Supplementary Methods). Final 21 dataset consisted of 32,677 whole exome sequences ( Figure 3A) . Similarly, to the experiment 22 with genotyping data that was described above, we randomly selected 3,000 European samples 1 as a "case" set and leftover 29,677 samples became a disjoined pool of controls ( Figure 3B) . We 2 used first 5 singular vectors to estimate residual norm for every sample in the control set and 3 create a control ranking (Figure 3C) , which distinctly separated ancestral groups ( Figure 3D) . 4
Increase in residual norm results in departure from targeted European control cluster and 5 inflation of the association test statistic (Figure 3E,F) . Optimal control set size was defined as a 6 largest set of controls with genomic inflation factor less or equal to 1.05 or the smallest inflation 7 factor if no values below 1.05 are available ( Figure 3G) . In 100 random selections of "case" cohort 8 (3000 Europeans each) on mean control set size was 17,435 (SD=921.97) with genomic inflation 9 factor mean lGC=1.056 (SD=0.012) ( Figure 3H) . 10 We analyzed how number of selected for analysis singular vectors affects size of matched 11 controls cohort. Upon increase in number of singular vectors, more variance could be explained 12 in limited reconstruction of the original matrix (e.g. if both U, S, V matrices are available for 13 original genotype matrix, its reconstruction using first several vectors of U matrix would capture 14 the variance better if more vectors are used, Supplementary Figure S6A,B) . Though, since in our 15 algorithm no matrix reconstruction is performed, there is no significant dependence of matched 16 controls cohort size on the size of the case-derived basis (Supplementary Figure S6C,D) . Thus, it 17 is reasonable to use only first few singular vectors to increase computation speed. 18
19

Controlling for technical bias 20
In the above examples, genotyping or sequencing data was processed in the uniform way 21 and in case of exomes -variants were called jointly, an action which is impossible without explicit 22 genotype sharing. Thus, we looked into effects of technical biases on the remote case-control 1 matching. We used publicly available 1000 genomes Phase 3 data 10 to select 46 samples (CEU 2 ancestry), that were also present in our exome control pool dataset and attempted to match 3 them to a control group. For this analysis control pool dataset was modified to exclude all 1000 4 genomes samples. Samples with known cancer phenotype were also excluded for further use of 5 this data as a public database of controls (Supplementary Figure S7A) . Both "external" and jointly 6 processed 1000 genomes samples were acceptably matched to a group of controls 7 (Supplementary Figure S7B-D) , with exactly the same 5963 control candidates selected for both 8 case groups and 1 additional control matched to "internal" cases. Important to note, that 9 external 1000 genomes exomes were sequenced using similar to control pool's Agilent exome 10 capture kit. Therefore, we conclude that separate variant calling does not introduce major 11 technical biases within the proposed approach. 12
One the level of experimental design, difference in DNA sequence capture used for exome 13 sequencing are known to introduce major effects in variant calling and cannot be cross-used for 14 association tests even if variants are jointly called 9,11 . The proposed approach will automatically 15 treat platform-based bias as a kind of "ancestry"-matching and control candidates from the same 16 sequencing platform would be prioritized over other options. However, in this initial release of 17 17,000 we only provide the control samples sequenced with Whole Exome Agilent 1.1 RefSeq 18 plus 3 boosters capture. Being the most represented capture in ExAC (~77%) 9 covers a major part 19 of sequenced samples to date. 20
Additional data quality metrics: depth, missing data rate could be directly shared between 21 control server and case client. Even with direct sharing of genotypes further work needs to be 22 done to get a gold-standard association study: lining up depth and accuracy at every site, gene, 1 exon. While control platform described here will ensure ancestral and platform matching it is up 2 to a researcher to match quality metrics and conduct careful statistical analysis. 3 (out of 16,946 candidate controls in SCoRe) to the same case group in jointly called dataset. Table S2 ). We provide a list of variants available for matching in 22
Statistical power is a key to successful association study and control set size is often a 12 limiting factor. Despite potential availability of control sets through public repositories, large 13 efforts should be put into processing case and control datasets jointly before even preliminary 14 results of an association study could emerge. Practically, this often becomes infeasible for the 15 small cohort studies limited to data access or computational power. Assembly of large case-16 control datasets is generally done by international consortia (ExAC, PGC, IBD Genetics 17 Consortium, etc.) as this requires a lot of effort and generous funding. We provide a large pool 18 of exome sequences and a tool enabling rapid selection of matched control sets without 19 genotype sharing that ultimately provides allele frequency statistics required for performing 20 association tests. Nearly no effort is required from the user side to get all information needed for 21 association study, facilitating future discovery of associated genes and DNA variants. 22 1 counselling often have very modestly sized or none control sets and stringent sharing regulation. 2
Our platform enables case-control study design and boosts statistical power for such patient 3 cohorts. Especially, for rare mendelian phenotypes where assembly of well-powered case-control 4 cohort is impeded by low disease prevalence. 5
Finally, hundreds of thousands samples were subjected to exome or genome sequencing 6 to date in the world. However, all this data exists in isolated pieces limiting potential benefit for 7 genetic studies. We provide a repository of the software codes used for running the matching 8 platform so that it could readily be implemented by large data holders -National biobank 9 initiatives and international disease consortia to let community benefit from large-scale genetic 10 resources. This is also critically important for advancing genetic association studies in situations 11 when explicit data sharing is not permitted or very challenging in the international settings, thus 12 potentially providing insights into rare sample collections that were not available so far. Finally, 13 approach developed in this work creates a path to creating unified central repository that would 14 encompass all studies published in dbGAP and make it accessible to association studies run in 15 any design and cohort. Dataset was subjected to variant and samples quality check, according to the standard 6 genotyping data handling protocol (Supplementary Figure S2) 6,7 . Quality check was performed 7 with PLINK package 13 . Code for converting binary PLINK format files into genotype matrix used 8 for matching is available through a control matching web-portal at 9 10
Exome Sequencing Data 11
Whole exome libraries were prepared using Whole Exome Agilent 1.1 RefSeq plus 3 boosters 12 capture kit and protocol, automated on the Agilent Bravo and Hamilton Starlet. Libraries were 13 then prepared for sequencing using a modified version of the manufacturer's suggested 14 protocol, automated on the Agilent Bravo and Hamilton Starlet, followed by sequencing on the 15 Illumina HiSeq 2000. We used an aggregated set of samples consented for joint variant calling 16 resulting in 37,607 samples (Supplementary Table S1 ). All samples were sequenced using the 17 same capture reagents at the Broad Institute and aligned on the reference genome with BWA data is subject to data sharing restrictions. SVD-based processing creates anonymous data 3 describing variation in case genotypes without storing individual data that could be shared with 4 no restrictions. Remote server with a pool of controls selects a set of controls genotype 5 variation matching cases, estimates allele frequency for sites to be used for association study 6
and delivers results to the user. Figure S8) . 2 Fig. 1 . Scheme of an association study without genotype sharing. Individual level genotype data is subject to data sharing restrictions. SVD-based processing creates anonymous data describing variation in case genotypes without storing individual data that could be shared with no restrictions. Remote server with a pool of controls selects a set of controls genotype variation matching cases, estimates allele frequency for sites to be used for association study and delivers results to the user. 
